Assignee
ESPERION THERAPEUTICS INC
US·51 granted patents·23 pending applications·1,684 citations·filing 1997–2024
Top patents by PatentIndex Score
74 records- 0199US6506799B1Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compoundsESPERION THERAPEUTICS INC·Filed 2000·Granted Jan 14, 2003·158 cites·27 claims
- 0298US9624152B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·17 cites·14 claims
- 0398US9452964B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2015·Granted Sep 27, 2016·22 cites·20 claims
- 0497US10118881B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2017·Granted Nov 6, 2018·14 cites·21 claims
- 0597US7576130B2Dihydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2007·Granted Aug 18, 2009·30 cites·5 claims
- 0697US7405226B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2006·Granted Jul 29, 2008·38 cites·12 claims
- 0797US6459003B1Ether compoundsESPERION THERAPEUTICS INC·Filed 2000·Granted Oct 1, 2002·80 cites·7 claims
- 0897US6410802B1Methods for synthesizing ether compounds and intermediates thereforESPERION THERAPEUTICS INC·Filed 2000·Granted Jun 25, 2002·81 cites·5 claims
- 0996US10941095B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2018·Granted Mar 9, 2021·3 cites·24 claims
- 1096US10047028B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2016·Granted Aug 14, 2018·12 cites·9 claims
- 1196US9006290B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2013·Granted Apr 14, 2015·17 cites·10 claims
- 1296US8623915B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2012·Granted Jan 7, 2014·20 cites·20 claims
- 1396US7838554B2Dihydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2009·Granted Nov 23, 2010·21 cites·13 claims
- 1496US7812199B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2007·Granted Oct 12, 2010·24 cites·26 claims
- 1596US7335799B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Feb 26, 2008·49 cites·18 claims
- 1696US6831105B2Compositions comprising ether compounds and pharmaceutical uses thereforESPERION THERAPEUTICS INC·Filed 2002·Granted Dec 14, 2004·48 cites·17 claims
- 1796US6680203B2Fourier transform mass spectrometry of complex biological samplesESPERION THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2004·146 cites·32 claims
- 1896US6646170B2Intermediates for the synthesis of ether compoundsESPERION THERAPEUTICS INC·Filed 2002·Granted Nov 11, 2003·51 cites·2 claims
- 1995US7119221B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Oct 10, 2006·32 cites·6 claims
- 2095US6790953B2Ether compoundsESPERION THERAPEUTICS INC·Filed 2002·Granted Sep 14, 2004·52 cites·1 claims
- 2195US6703422B2Sulfide and disulfide compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Mar 9, 2004·90 cites·16 claims
- 2295US6673780B2Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·88 cites·9 claims
- 2394US7335689B2Dihydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Feb 26, 2008·27 cites·31 claims
- 2494US7192940B2Ether compoundsESPERION THERAPEUTICS INC·Filed 2004·Granted Mar 20, 2007·37 cites·3 claims
- 2594US6909014B2Intermediates for the synthesis of ether compoundsESPERION THERAPEUTICS INC·Filed 2003·Granted Jun 21, 2005·35 cites·1 claims
- 2694US6699910B2Ketone compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Mar 2, 2004·77 cites·17 claims
- 2792US7304093B2Ketone compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Dec 4, 2007·34 cites·25 claims
- 2892US6713507B2Ether compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Mar 30, 2004·52 cites·19 claims
- 2991US6423830B1Process for purifying apolipoprotein A or apolipoprotein EESPERION THERAPEUTICS INC·Filed 2000·Granted Jul 23, 2002·39 cites·7 claims
- 3091US6329341B1Method of treating septic shockESPERION THERAPEUTICS INC·Filed 1999·Granted Dec 11, 2001·61 cites·21 claims
- 3190US12398087B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2024·Granted Aug 26, 2025·0 cites·17 claims
- 3289US2024286987A1Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3388US12404227B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2023·Granted Sep 2, 2025·0 cites·20 claims
- 3488US11407705B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·1 cites·20 claims
- 3587US2023210800A1Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3686US11926584B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2023·Granted Mar 12, 2024·0 cites·20 claims
- 3785US2020189999A1Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3884US6617134B1Dimer of molecular variant of apolipoprotein and processes for the production thereofESPERION THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·56 cites·18 claims
- 3983US11987548B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2022·Granted May 21, 2024·0 cites·20 claims
- 4082US11744816B2Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·1 cites·8 claims
- 4182US11613511B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2022·Granted Mar 28, 2023·0 cites·17 claims
- 4282US11116739B2Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2016·Granted Sep 14, 2021·2 cites·1 claims
- 4382US8975300B2Ketone compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2013·Granted Mar 10, 2015·3 cites·8 claims
- 4482US6953840B2Methods of using non-human animal Apolipoprotein A-I proteinESPERION THERAPEUTICS INC·Filed 2003·Granted Oct 11, 2005·21 cites·33 claims
- 4582US6090921AProcess for purifying apolipoprotein a or apolipoprotein eESPERION THERAPEUTICS INC·Filed 1997·Granted Jul 18, 2000·45 cites·24 claims
- 4682US2021395175A1Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4781US11760714B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2022·Granted Sep 19, 2023·0 cites·20 claims
- 4880US2025064767A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4976US2024148681A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 5075US6559284B1Process for purifying a proteinESPERION THERAPEUTICS INC·Filed 1997·Granted May 6, 2003·30 cites·4 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →